Biologics
PeptiDream And Alnylam Reach Key Preclinical Milestone In Precision siRNA Delivery
PeptiDream Inc., a public Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter “PeptiDream”)(Tokyo: 4587), announced ...
December 22, 2025 | News
Qihan Biotech Initiates Phase I IIa Dosing Of Allogeneic CAR T Therapy For Refractory Lupus
Qihan Biotech, a clinical-stage biotechnology company developing off-the-shelf cell therapies for autoimmune diseases and cancer, including allogeneic CAR-...
December 22, 2025 | News
Soin Neuroscience And BIOTRONIK Neuro Advance Personalised Spinal Cord Stimulation Research
Soin Neuroscience and BIOTRONIK Neuro announced a research collaboration to advance personalized spinal cord stimulation (SCS) tuning using Soin Neuroscien...
December 22, 2025 | News
MEDI&GENE Enters Catalyze Agreement With Eli Lilly To Advance Next Generation Obesity Therapy
MEDI&GENE, a biopharmaceutical company developing therapeutics for metabolic diseases, announced today that it has entered into a Catalyze agreeme...
December 19, 2025 | News
PeptiDream Advances Oral Dual IL17 Inhibitor Into Clinical Development Portfolio
PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter “PeptiDream”)(Tokyo: 4587) a...
December 19, 2025 | News
Galux Partners With Boehringer Ingelheim To Advance AI Driven Precision Protein Design
-Galux, a South Korean biotech pioneering AI-driven protein therapeutics discovery, announced that it has signed a research agreement with Boehr...
December 19, 2025 | News
Talus Bioscience Enters Strategic Collaboration With PRISM BioLab To Unlock Transcription Driven Drug Targets
Talus Bioscience, Inc. (“Talus Bio”), an AI-enabled regulome therapeutics company, today announced a strategic collaboration with PRI...
December 19, 2025 | News
Harbour BioMed Enters Global Antibody Collaboration With Bristol Myers Squibb
Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunolo...
December 18, 2025 | News
Sanofi And Dren Bio Expand Strategic Collaboration To Advance Next Generation B Cell Depleting Therapies In Autoimmune Disease
– New collaboration builds on Sanofi’s prior acquisition of DR-0201 and further leverages Dren Bio’s proprietary Targeted Myeloid Engag...
December 17, 2025 | News
GenSci, RTW And Yarrow Forge US Focused Biotech Partnership To Advance First In Class Thyroid Autoimmune Therapy
Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients impacted by autoimmune and endocrinology di...
December 17, 2025 | News
Thermo Fisher Scientific Advances Microbial Bioprocessing With Chemically Defined Media For Confident Plasmid DNA And Protein Scale Up
New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence Thermo Fisher Scientific In...
December 16, 2025 | News
Everest Medicines Enters Dual Strategic Agreements with Hasten to Drive Accretive Growth
- Accretive Commercialization Services Agreement covering six mature assets across critical care, cardiovascular, and metabolic disease leveragi...
December 15, 2025 | News
D3 Bio Secures One Hundred 8M$ In Series B Funding To Advance Global Late Stage Oncology Trials
D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completio...
December 11, 2025 | News
Innovent Doses First Participant in Phase One Trial of Novel IL One RAP Antibody for Gout
Innovent Biologics, Inc. , a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment ...
December 11, 2025 | News
Most Read
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
